Eicosanoids in exhaled breath condensate and bronchoalveolar lavage fluid of patients with primary lung cancer

Disease Markers

Volumn 32, Issue 5, 2012, Pages 329-335

  Ciebiada, MacIej ^a   Górski, Paweł ^a   Antczak, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

broncholaveolar lavage; early detection; Exhaled breath condensate; leukotrienes; lung cancer; prostaglandins

Indexed keywords

8 ISOPROSTANE; LEUKOTRIENE B4; PROSTAGLANDIN E2;

ADULT; ARTICLE; BASOPHIL; CANCER EPIDEMIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EXHALED BREATH CONDENSATE; EXPIRED AIR; FEMALE; HUMAN; HUMAN CELL; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; SMOKING;

EID: 84861525156     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0890     Document Type: Article

References (29)

1. K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, S. Loukides, Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma, Chest 127 (2005), 1553-1559. (Pubitemid 46218778)
2. G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, S. A. Kharitonov, Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 125 (2004), 2005-2010. (Pubitemid 38788163)
3. S. Carraro, B. Andreola, R. Alinovi, M. Corradi, L. Freo, L. Da Dalt, E. Baraldi, Exhaled leukotriene B4 in children with community acquired pneumonia, Pediatr Pulmonol 43 (2008), 982-986.
4. W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, P. Górski, Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis, Chest 132 (2007), 589-596. (Pubitemid 47282393)
5. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, P. J. Barnes, 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy, Chest 124 (2003), 1386-1392. (Pubitemid 37290049)
6. G. E. Carpagnano, A. Spanevello, G. P. Palladino, C. Gram-iccioni, C. Ruggieri, F. Carpagnano, M. P. Foschino Barbaro, Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link? Lung Cancer 67 (2010), 108-113.
7. M. Luo, S. Lee, T. G. Brock, Leukotriene synthesis by epithelial cells, Histol Histopathol 18 (2003), 587-595. (Pubitemid 36362076)
8. A. Katsabeki-Katsafli, T. Kerenidi, K. Kostikas, E. Dalaveris, T. S. Kiropoulos, E. Gogou, A. I. Papaioannou, K. I. Gourgou-lianis, Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer, Lung Cancer 60 (2008), 271-276
9. British Thoracic Society Bronchoscopy Guidlines Committee, a Subcommittee of the Standards of Care Committee of the British Thoracic Society, British Thoracic Society guidelines on diagnostic flexible bronchoscopy, Thorax 56 (2001), 1-21.
10. A. Antczak, P. Montuschi, S. A. Kharitonov, P. Gorski, P. J. Barnes, Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma, Am J Respir Crit Care Med 166 (2002), 301-306. (Pubitemid 34864417)
11. P. Montuschi, E. Ragazzoni, E. Valente, G. Corbo, C. Mondi-no, G. Ciappi, P. J. Barnes, G. Ciabattoni, Validation of leukotriene B4 measurements in exhaled breath condensate, Inflamm Res 52 (2003), 69-73. (Pubitemid 36286704)
12. P. Montuschi, M. Corradi, G. Ciabattoni, J. Nightingale, S. A. Kharitonov, P. J. Barnes, Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients, Am J Respir Crit Care Med 160 (1999), 216-220. (Pubitemid 29326091)
13. P. E. Silkoff, S. C. Erzurum, J. O. Lundberg, S. C. George, N. Marczin, J. F. Hunt, R. Effros, I. Horvath, ATS Workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate, Proc Am Thorac Soc 3 (2006), 131-145.
14. S. K. Huang, M. Peters-Golden, Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? Chest 133 (2008), 1442-1450. (Pubitemid 351899641)
15. S. H. Hong, I. Avis, M. D. Vos, A. Martinez, A. M. Treston, J. L. Mulshine, Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors, Cancer Res 59 (1999), 2223-2228. (Pubitemid 29217689)
16. E. Dalaveris, T. Kerenidi, A. Katsabeki-Katsafli, T. Kiropou-los, K. Tanou, K. Gourgoulianis, K. Kostikas, VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer, Lung Cancer 64 (2009), 219-225.
17. P. Montuschi, P. J. Barnes, Exhaled leukotrienes and prostaglandins in asthma, J Allergy Clin Immunol 109 (2002), 615-620. (Pubitemid 34327186)
18. M. Takano, H. Nishimura, Y. Kimura, J. Washizu, Y. Mokuno, Y. Nimura, Y. Yoshikai, Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice, J Immunol 161 (1998), 3019-3025. (Pubitemid 28425727)
19. M. J. Cruz, S. Sánchez-Vidaurre, P. V. Romero, F. Morell, X. Munoz, Impact of age on pH, 8-isoprostane, and nitrogen oxides in exhaled breath condensate, Chest 135 (2009), 462-467.
20. R. M. Breyer, C. K. Bagdassarian, S. A. Myers, M. D. Breyer, Prostanoid receptors: subtypes and signaling, Annu Rev Pharmacol Toxicol 41 (2001), 661-690. (Pubitemid 32385902)
21. A. leFever, A. Funahashi, Elevated prostaglandin E2 levels in broncholalveolar lavage fluid of patients with bronchogenic carcinoma, Chest 98 (1990), 1397-1402.
22. A. Funahashi, R. W. Harland, A. LeFever, Association of increased prostaglandin E2 content in bronchoalveolar lavage fluid and intrathoracic malignancy, Chest 106 (1994), 166-172. (Pubitemid 24214748)
23. 4 on bovine aortic en-dothelial cell proliferation in vitro, Prostaglandins 33 (1987), 531-538. (Pubitemid 17115689)
24. H. Amano, I. Hayashi, H. Endo, H. Kitasato, S. Yamashina, T. Maruyama, M. Kobayashi, K. Satoh, M. Narita, Y. Sugimoto, T. Murata, H. Yoshimura, S. Narumiya, M. Majima, Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth, J Exp Med 197 (2003), 221-232. (Pubitemid 36152316)
25. E. Pace, M. Profita, M. Melis, A. Bonanno, A. Paternò, C. H. Mody, M. Spatafora, M. Ferraro, L. Siena, A. M. Vignola, G. Bonsignore, M. Gjomarkaj, LTB4 is present in exudative pleu-ral effusions and contributes actively to neutrophil recruitment in the inflamed pleural space, Clin Exp Immunol 135 (2004), 519-527. (Pubitemid 38297156)
26. A. J. Duffield-Lillico, J. O. Boyle, X. K. Zhou, A. Ghosh, G. S. Butala, K. Subbaramaiah, R. A. Newman, J. D. Morrow, G. L. Milne, A. J. Dannenberg, Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway, Cancer Prev Res 2 (2009), 322-332.
27. A. Antczak, W. J. Piotrowski, J. Marczak, M. Ciebiada, P. Gorski, P. J. Barnes, Correlation between eicosanoids in bron-choalveolar lavage fluid and in exhaled breath condensate, Dis Markers 30 (2011), 213-220.
28. K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, S. Loukides, Oxidative stress in expired breath condensate of patients with copd, Chest 124 (2003), 1373-1380. (Pubitemid 37290047)
29. E. Ono, H. Mita, M. Taniguchi, N. Higashi, T. Tsuburai, E. Miyazaki, T. Kumamoto, K. Akiyama, Comparison of cys-teinyl leukotriene concentrations between exhaled breath condensate and bronchoalveolar lavage fluid, Clin Exp Allergy 38 (2008), 1866-1874.